A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects
This study has been completed.
Study NCT00402077
Information provided by Amylin Pharmaceuticals, Inc.
First Received: November 17, 2006
Last Updated: January 8, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
